Why healthcare transparency without technology, accountability, and enforcement fails to reduce costs or improve patient access.

"The Great Healthcare Plan" aims to lower drug costs, reduce premiums, and enhance price transparency, with a focus on Most Favored Nation drug pricing. The plan proposes direct payments to individuals for insurance, replacing government subsidies, and aims to eliminate pharmacy benefit manager kickbacks.

U.S. Rep. Pete Sessions, (R-Texas), is chairman of the House Subcommittee on Government Operations. John C. Goodman, author of “Priceless: Curing the Healthcare Crisis,” is a senior fellow at the Independent Institute and president of the Goodman Institute.

The reemergence of the debate over the now-expired Affordable Care Act (ACA) enhanced premium tax credits has thrust the issue to the forefront. And along with it, the deeply misleading framing that millions of Americans have lost or are losing coverage because of the loss of government subsidies. A reality check is in order.

Midterm elections and surging healthcare costs are colliding in 2026. Here’s what these pressures may force politicians, insurers and drugmakers to do.

Sen. Rick Scott replies to Rep. Mike Lawler.

Well-known and well-respected surgeon Atul Gawande, MD, is discussing healthcare reform and his opinion is worth reading. He helps put health reform costs in perspective in his latest article for The New Yorker. Gawande is a staff member of Brigham and ...